2 unknown. 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Idarubicin(IDA): new trials by email Literature Review of Idarubicin(IDA) trials Research Report on Idarubicin(IDA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia Dasatinib - Acute Myeloid Leukemia | Not applicable | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 132 | 2016-08-01 | 2022-08-03 |
| Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia Idarubicin(IDA) - Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome, Ph^1^, Absent | Phase 4 | Unknown | Chinese Academy of Medical Sciences | 20 | 2012-10-01 | 2013-11-21 |
Leukemia, Myeloid, Acute (1) · Philadelphia Chromosome (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Chinese Academy of Medical Sciences (1) · Institute of Hematology & Blood Diseases Hospital, China (1)
China (2)
Xiaofan Zhu, MD (1) · Zhu Xiaofan (1)